Trial Profile
Endocrine and Emotional Effects of Lisdexamfetamine and d- Amphetamine: a Placebo-controlled Study in Healthy Subjects (LisDexStudy)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Apr 2019
Price :
$35
*
At a glance
- Drugs Dexamfetamine (Primary) ; Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder; Bipolar depression; Eating disorders; Major depressive disorder; Mood disorders; Schizophrenia; Sleep disorders
- Focus Therapeutic Use
- Acronyms LisDex
- 22 Dec 2016 Status changed from active, no longer recruiting to completed.
- 29 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 09 May 2016 Status changed from not yet recruiting to recruiting.